(“NetScientific” or the “Company” or the “Group”)
Notice of Interim Results
London, UK – 6 September 2016 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that it will report its interim results for the six months ended 30 June 2016 on Tuesday 27 September2016.
An analyst presentation will be held at the offices of Stifel Nicholaus Europe at 150 Cheapside, London EC2V 6ET at 12.00pm on Tuesday 27 September 2016.
– Ends –
For more information, please contact:
|
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO
|
Tel: +44 (0)20 3514 1800 |
|
Stifel Nicolaus Europe Limited (NOMAD and broker) Jonathan Senior / David Arch / Ben Maddison |
Tel: +44 (0)20 7710 7600 |
|
Consilium Strategic Communications Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton
|
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
About NetScientific Plc
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net.
END
NORAKPDKABKDDCK
